Stay updated on Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:49.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page shows a new site revision note (Revision: v3.4.2) and removes an older funding-status warning and Revision: v3.4.1; these are maintenance updates rather than changes to the trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:50:23.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice informing users that information may not be up to date and linking to cc.nih.gov and opm.gov for status updates. The page now shows Revision: v3.4.1, replacing the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T00:33:11.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary was added and QC-related metadata was updated (Last Update Submitted that Met QC Criteria and Revision: v3.4.0). The previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-27T23:44:07.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T01:18:31.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a 'Locations' section with an 'Arizona' entry and removed the separate 'Arizona Locations' heading, altering how study sites are displayed.
    Difference
    0.2%
    Check dated 2025-12-23T12:42:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.